{"id":"W2155311724","doi":"10.1056/nejmoa0804385","title":"<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":3597,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cetuximab; Medicine; Colorectal cancer; Hazard ratio; Internal medicine; Oncology; Progression-free survival; Cancer; Exon; Confidence interval; Chemotherapy; Gene; Biology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}